Free triiodothyronine and global registry of acute coronary events risk score on predicting long-term major adverse cardiac events in STEMI patients undergoing primary PCI
| Autor: | Hao Wang, Ming-Ming Zhang, Shouyan Zhang, Chunguang Qiu, Caifeng Fan, Xue-Wei Chang, Yunfei Gu, Jinghan Wei |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2018 |
| Předmět: |
Male
medicine.medical_specialty Endocrinology Diabetes and Metabolism medicine.medical_treatment Clinical Biochemistry Clinical nutrition Kaplan-Meier Estimate 030204 cardiovascular system & hematology Percutaneous coronary intervention 03 medical and health sciences 0302 clinical medicine Endocrinology Internal medicine medicine Humans 030212 general & internal medicine Myocardial infarction cardiovascular diseases lcsh:RC620-627 Aged Framingham Risk Score business.industry Research Biochemistry (medical) Area under the curve Free triiodothyronine Middle Aged medicine.disease Prognosis lcsh:Nutritional diseases. Deficiency diseases ROC Curve Conventional PCI Cardiology ST Elevation Myocardial Infarction Triiodothyronine Female business Mace |
| Zdroj: | Lipids in Health and Disease Lipids in Health and Disease, Vol 17, Iss 1, Pp 1-10 (2018) |
| ISSN: | 1476-511X |
| Popis: | Background The aim of this study is to investigate the combined value of fT3 and GRACE risk score for cardiovascular prognosis in ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI). Methods Three hundred and thirty eight patients with STEMI who received successful primary PCI were enrolled in our study. All patients underwent (33.5 ± 7.1) month’s follow-up. Mace was defined as cardiac death and nonfatal myocardial infarction. Results Multivariate Cox analysis showed that both fT3 (HR = 0.462, 95%CI: 0.364–0.587, P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink